Tekla Capital Management as of Sept. 30, 2016
Portfolio Holdings for Tekla Capital Management
Tekla Capital Management holds 142 positions in its portfolio as reported in the September 2016 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Gilead Sciences (GILD) | 8.1 | $211M | 2.7M | 79.12 | |
Celgene Corporation | 6.0 | $155M | 1.5M | 104.53 | |
Biogen Idec (BIIB) | 5.8 | $151M | 482k | 313.03 | |
Allergan | 3.8 | $100M | 434k | 230.31 | |
Alexion Pharmaceuticals | 3.6 | $94M | 764k | 122.54 | |
Vertex Pharmaceuticals Incorporated (VRTX) | 3.5 | $90M | 1.0M | 87.21 | |
Incyte Corporation (INCY) | 3.2 | $83M | 881k | 94.29 | |
Merck & Co (MRK) | 3.0 | $78M | 1.2M | 62.41 | |
BioMarin Pharmaceutical (BMRN) | 2.5 | $66M | 710k | 92.52 | |
Regeneron Pharmaceuticals (REGN) | 2.4 | $62M | 154k | 402.02 | |
Abbott Laboratories (ABT) | 2.2 | $58M | 1.4M | 42.29 | |
Eli Lilly & Co. (LLY) | 2.2 | $57M | 714k | 80.26 | |
Medtronic (MDT) | 2.1 | $54M | 623k | 86.40 | |
Amgen (AMGN) | 2.1 | $54M | 322k | 166.81 | |
UnitedHealth (UNH) | 1.8 | $46M | 331k | 140.00 | |
Shire | 1.7 | $45M | 231k | 193.86 | |
Illumina (ILMN) | 1.7 | $45M | 247k | 181.66 | |
Mylan Nv | 1.7 | $43M | 1.1M | 38.12 | |
Jazz Pharmaceuticals (JAZZ) | 1.6 | $40M | 331k | 121.48 | |
Johnson & Johnson (JNJ) | 1.5 | $40M | 337k | 118.13 | |
Pfizer (PFE) | 1.5 | $39M | 1.1M | 33.87 | |
CVS Caremark Corporation (CVS) | 1.4 | $37M | 412k | 88.99 | |
Teva Pharmaceutical Industries (TEVA) | 1.4 | $36M | 789k | 46.01 | |
Neurocrine Biosciences (NBIX) | 1.3 | $33M | 657k | 50.64 | |
Humana (HUM) | 1.1 | $29M | 165k | 176.89 | |
Alkermes (ALKS) | 1.1 | $27M | 582k | 47.03 | |
AmerisourceBergen (COR) | 1.0 | $27M | 331k | 80.78 | |
Molina Healthcare (MOH) | 0.9 | $24M | 403k | 58.32 | |
Agilent Technologies Inc C ommon (A) | 0.8 | $22M | 460k | 47.09 | |
Medicines Company | 0.8 | $21M | 564k | 37.74 | |
Novartis (NVS) | 0.8 | $20M | 249k | 78.96 | |
Endo International | 0.7 | $18M | 915k | 20.15 | |
Cepheid | 0.7 | $18M | 334k | 52.69 | |
Puma Biotechnology (PBYI) | 0.7 | $17M | 260k | 67.05 | |
Centene Corporation (CNC) | 0.7 | $17M | 257k | 66.96 | |
Universal Health Services (UHS) | 0.6 | $17M | 135k | 123.22 | |
iShares NASDAQ Biotechnology Index (IBB) | 0.6 | $17M | 58k | 289.46 | |
Alnylam Pharmaceuticals (ALNY) | 0.6 | $17M | 244k | 67.78 | |
GlaxoSmithKline | 0.6 | $16M | 359k | 43.13 | |
AstraZeneca (AZN) | 0.6 | $15M | 464k | 32.86 | |
IDEXX Laboratories (IDXX) | 0.6 | $15M | 132k | 112.73 | |
Omega Healthcare Investors (OHI) | 0.6 | $15M | 413k | 35.45 | |
Thermo Fisher Scientific (TMO) | 0.5 | $14M | 86k | 159.06 | |
Horizon Pharma | 0.5 | $14M | 750k | 18.13 | |
Zimmer Holdings (ZBH) | 0.5 | $13M | 102k | 130.02 | |
Sarepta Therapeutics (SRPT) | 0.5 | $13M | 214k | 61.41 | |
Welltower Inc 6.50% pfd prepet | 0.5 | $13M | 200k | 66.55 | |
Senior Housing Properties Trust | 0.5 | $13M | 575k | 22.71 | |
Medical Properties Trust (MPW) | 0.5 | $12M | 839k | 14.77 | |
Cardinal Health (CAH) | 0.5 | $12M | 153k | 77.70 | |
Cytomx Therapeutics (CTMX) | 0.5 | $12M | 756k | 15.68 | |
Sanofi-Aventis SA (SNY) | 0.5 | $12M | 305k | 38.19 | |
Becton, Dickinson and (BDX) | 0.4 | $11M | 63k | 179.73 | |
Sabra Health Care REIT (SBRA) | 0.4 | $12M | 456k | 25.18 | |
Physicians Realty Trust | 0.4 | $11M | 531k | 21.54 | |
CIGNA Corporation | 0.4 | $11M | 86k | 130.32 | |
United Therapeutics Corporation (UTHR) | 0.4 | $11M | 93k | 118.08 | |
DaVita (DVA) | 0.4 | $11M | 161k | 66.07 | |
Ventas (VTR) | 0.4 | $11M | 153k | 70.63 | |
Endologix | 0.4 | $9.9M | 774k | 12.80 | |
Paratek Pharmaceuticals | 0.4 | $9.9M | 763k | 13.01 | |
Natera (NTRA) | 0.4 | $9.8M | 882k | 11.11 | |
Charles River Laboratories (CRL) | 0.4 | $9.6M | 115k | 83.34 | |
Galapagos Nv- (GLPG) | 0.4 | $9.6M | 148k | 64.66 | |
Supernus Pharmaceuticals note 7.500 5/0 | 0.4 | $9.3M | 2.0M | 4.67 | |
Ardelyx (ARDX) | 0.3 | $9.2M | 708k | 12.94 | |
Foamix Pharmaceuticals | 0.3 | $8.9M | 966k | 9.26 | |
Aegerion Pharmaceuticals 2% Du cvbond | 0.3 | $8.6M | 13M | 0.66 | |
Flamel Technologies | 0.3 | $7.7M | 624k | 12.40 | |
Cellectis S A (CLLS) | 0.3 | $7.5M | 310k | 24.08 | |
Pieris Pharmaceuticals | 0.3 | $7.6M | 4.1M | 1.83 | |
Hca Holdings (HCA) | 0.3 | $7.2M | 96k | 75.63 | |
Retrophin | 0.3 | $7.4M | 330k | 22.38 | |
Exelixis (EXEL) | 0.3 | $7.1M | 552k | 12.79 | |
Ariad Pharmaceuticals | 0.3 | $6.9M | 502k | 13.69 | |
Sage Therapeutics (SAGE) | 0.3 | $6.8M | 147k | 46.05 | |
Ultragenyx Pharmaceutical (RARE) | 0.2 | $6.3M | 88k | 70.94 | |
Egalet Corporation note 5.50% 4/1/20 | 0.2 | $6.0M | 7.0M | 0.85 | |
Xenon Pharmaceuticals (XENE) | 0.2 | $5.7M | 700k | 8.10 | |
Pra Health Sciences | 0.2 | $5.8M | 102k | 56.51 | |
LTC Properties (LTC) | 0.2 | $5.5M | 106k | 51.99 | |
Icon (ICLR) | 0.2 | $5.6M | 72k | 77.38 | |
Juno Therapeutics | 0.2 | $5.5M | 182k | 30.01 | |
Vitae Pharmaceuticals | 0.2 | $5.2M | 250k | 20.92 | |
DepoMed | 0.2 | $5.0M | 200k | 24.99 | |
Karyopharm Therapeutics (KPTI) | 0.2 | $4.9M | 500k | 9.73 | |
New Senior Inv Grp | 0.2 | $5.0M | 431k | 11.54 | |
Valeant Pharmaceuticals Int | 0.2 | $4.7M | 192k | 24.55 | |
Mallinckrodt Pub | 0.2 | $4.3M | 62k | 69.77 | |
Merus N V (MRUS) | 0.2 | $4.4M | 260k | 16.75 | |
Allergan Plc pfd conv ser a | 0.2 | $4.1M | 5.0k | 821.60 | |
Akorn | 0.1 | $4.0M | 145k | 27.26 | |
Epizyme | 0.1 | $3.9M | 400k | 9.84 | |
Adaptimmune Therapeutics (ADAP) | 0.1 | $4.0M | 566k | 7.05 | |
Community Health Systems (CYH) | 0.1 | $3.5M | 305k | 11.54 | |
ACADIA Pharmaceuticals (ACAD) | 0.1 | $3.6M | 112k | 31.81 | |
Tenet Healthcare Corporation (THC) | 0.1 | $3.7M | 165k | 22.66 | |
Dynavax Technologies (DVAX) | 0.1 | $3.6M | 345k | 10.49 | |
Beigene | 0.1 | $3.6M | 117k | 30.81 | |
Accelr8 Technology | 0.1 | $3.3M | 120k | 27.26 | |
Bluebird Bio (BLUE) | 0.1 | $3.3M | 49k | 67.79 | |
Perrigo Company (PRGO) | 0.1 | $3.4M | 37k | 92.33 | |
Immunomedics Inc note 4.750% 2/1 | 0.1 | $3.4M | 4.0M | 0.84 | |
Impax Laboratories | 0.1 | $2.9M | 124k | 23.70 | |
Forward Pharma A/s | 0.1 | $2.9M | 137k | 21.00 | |
Dermira | 0.1 | $2.8M | 83k | 33.83 | |
Global Blood Therapeutics In | 0.1 | $2.9M | 125k | 23.05 | |
McKesson Corporation (MCK) | 0.1 | $2.5M | 15k | 166.73 | |
Grifols S A Sponsored Adr R (GRFS) | 0.1 | $2.7M | 166k | 15.97 | |
Nevro (NVRO) | 0.1 | $2.6M | 25k | 104.40 | |
Allscripts Healthcare Solutions (MDRX) | 0.1 | $2.3M | 174k | 13.17 | |
Halozyme Therapeutics (HALO) | 0.1 | $2.4M | 200k | 12.08 | |
Diplomat Pharmacy | 0.1 | $2.4M | 87k | 28.01 | |
Dbv Technologies S A | 0.1 | $2.4M | 66k | 36.33 | |
Arca Biopharma | 0.1 | $2.3M | 811k | 2.89 | |
Therapeuticsmd | 0.1 | $2.1M | 307k | 6.81 | |
Momenta Pharmaceuticals | 0.1 | $1.8M | 154k | 11.69 | |
Amicus Therapeutics (FOLD) | 0.1 | $1.9M | 258k | 7.40 | |
Acadia Healthcare (ACHC) | 0.1 | $1.7M | 35k | 49.55 | |
Merrimack Pharmaceuticals In | 0.1 | $1.8M | 286k | 6.35 | |
Chimerix (CMRX) | 0.1 | $1.7M | 309k | 5.54 | |
Merrimack Pharmaceuticals In note 4.500% 7/1 | 0.1 | $1.9M | 1.5M | 1.27 | |
Uniqure Nv (QURE) | 0.1 | $1.8M | 241k | 7.65 | |
Inotek Pharmaceuticals | 0.1 | $1.7M | 181k | 9.48 | |
Flex Pharma | 0.1 | $1.9M | 162k | 11.78 | |
Cidara Therapeutics Inc Common Stock Usd 0.0001 | 0.1 | $1.5M | 133k | 11.45 | |
Novavax | 0.1 | $1.2M | 571k | 2.08 | |
Esperion Therapeutics (ESPR) | 0.1 | $1.4M | 103k | 13.85 | |
Alliqua | 0.1 | $1.3M | 1.7M | 0.78 | |
Revance Therapeutics (RVNC) | 0.1 | $1.2M | 75k | 16.21 | |
Auris Med Hldg | 0.1 | $1.3M | 775k | 1.73 | |
Bellicum Pharma | 0.1 | $1.2M | 60k | 19.90 | |
Intellia Therapeutics (NTLA) | 0.1 | $1.2M | 72k | 17.02 | |
GenMark Diagnostics | 0.0 | $1.1M | 93k | 11.81 | |
Tetraphase Pharmaceuticals | 0.0 | $737k | 192k | 3.83 | |
Affimed Therapeutics B V | 0.0 | $818k | 294k | 2.78 | |
Celldex Therapeutics | 0.0 | $427k | 106k | 4.04 | |
Xencor (XNCR) | 0.0 | $490k | 20k | 24.50 | |
Quorum Health | 0.0 | $477k | 76k | 6.27 | |
Rmr Group Inc cl a (RMR) | 0.0 | $282k | 7.4k | 37.90 | |
Abbvie (ABBV) | 0.0 | $10k | 156.00 | 64.10 | |
Zafgen | 0.0 | $44k | 13k | 3.31 |